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Abstract
Background: Falciparum malaria remains a major occupational illness that accounts for several
deaths per year and numerous lost working days among the expatriate population, working or living
in high-risk malarious areas. Compliance to preventive strategies is poor in travellers, especially
business travellers, expatriates and long-term travellers.
Methods: In this cross-sectional, web-based study the adherence to and outcome of a preventive
malaria programme on knowledge, attitudes and practices, including the practice of self-diagnosis
and standby treatment (curative malaria kit, CMK) was evaluated in 2,350 non-immune expatriates,
who had been working in highly malaria endemic areas.
Results: One-third (N = 648) of these expatriates visited a doctor for malaria symptoms and
almost half (29 of 68) of all hospitalizations were due to malaria. The mandatory malaria training
for non-immunes was completed by 92% of those who visited or worked in a high risk malaria
country; 70% of the respondents at risk also received the CMK. The malaria awareness training and
CMK significantly increased malaria knowledge [relative risk (RR) of 1.5, 95%CI 1.2–2.1], attitudes
and practices, including compliance to chemoprophylaxis [RR = 2.2, 95%CI 1.6–3.2].
Hospitalization for malaria tended to be reduced by the programme [RR = 0.4, 95%CI 0.1–1.1],
albeit not significantly. Respondents who did not receive instructions on the rapid diagnostic test
were two times [RR = 2.3, 95%CI 1.6–3.3] more likely to have difficulties. Those who did receive
instructions adhered poorly to the timing of repeating the test. Moreover, 6% (31 of 513) of those
with a negative test result were diagnosed with malaria by a local doctor. 77% (N = 393) of the
respondents with a negative test result did not take curative medication. 57% (252 of 441) of the
respondents who took the curative medication that was included in the kit did not have a positive
self-test or clinical malaria diagnosis made by a doctor.
Conclusion:  This survey demonstrated that a comprehensive programme targeting malaria
prevention in expatriates can be effectively implemented and that it significantly increased malaria
awareness.
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Background
Every year, Plasmodium falciparum infects 300 to 500 mil-
lion persons, and kills between one and two million. Par-
ticularly sub-Saharan Africa, parts of South America and
South-East Asia are affected. Falciparum malaria is also a
major occupational illness that accounts for several deaths
per year and numerous lost working days among the expa-
triate population, working or living in high-risk malarious
areas. Approximately 1% of all non-immune travellers
who acquire P. falciparum infection die [1].
Increasing awareness, personal protection measures
against mosquito bites, chemoprophylaxis, and early
diagnosis and treatment are the mainstay of prevention
against falciparum malaria. Compliance to these preven-
tive strategies is poor in travellers, especially business trav-
ellers, expatriates and long-term travellers [2]. Moreover,
the diagnosis of malaria is often not immediately consid-
ered in returning travellers, resulting in treatment delay
and subsequent higher morbidity [3].
In 2003, a preventive programme for international
employees and contractors working in malaria endemic
areas was set up by an oilfield service company to enhance
awareness on the dangers of malaria, and to reduce its
morbidity and mortality. The cornerstones of this preven-
tive programme were a malaria awareness training pro-
gramme and provision of a curative malaria kit, which
contained dipstick-based strips for self-diagnosis and
emergency standby medication for self-treatment of falci-
parum malaria. In an initial survey, this programme was
rated very good to excellent by more than 60% of the
respondents [4].
In this cross-sectional study by web-based questionnaire,
the adherence to this preventive malaria programme, and
the practice of self-diagnosis and standby treatment of
presumptive falciparum malaria in the field was evalu-
ated.
Methods
Malaria prevention programme
The malaria prevention programme consists of the follow-
ing components:
1. Malaria training for non-immunes. This training was
mandatory for all non-immune international oilfield
service company employees. Any person who had left a
malaria endemic country for more than six months was
considered non-immune to malaria.
2. Arrival packages were assigned to employees with high-
malaria-risk destinations, according to the WHO malaria
country definition [5]. A quiz was designed to enhance
the awareness of expatriate workers on the risks of malaria
and the possible preventive measures.
3. At all malarious locations appropriate preventive meas-
ures were provided, including insecticide treated bed nets,
routine malaria prophylaxis, insect repellents and insecti-
cide treatments to kill mosquito larvae in company facili-
ties and residences.
4. Malaria hot line. A toll-free telephone line, staffed by
multilingual doctors who were specialized in tropical dis-
eases, was available 24 hours a day, seven days a week.
5. A curative malaria kit (CMK) with hands-on training.
This kit was developed to address emergency cases of sus-
pected malaria in which an individual was more than 24
hours away from a medical centre. The kit consisted of
forehead temperature strips, three dipstick-based, immu-
nological antigen-capture self-tests for falciparum malaria
(Paracheck Pf® or Core Malaria Pf®, depending on availa-
bility), and curative medication (Coartem®: artemether/
lumefantrine). If the self-test was positive the infected per-
son was instructed to start taking the curative medication
(four tablets every morning and four tablets every evening
for three days), and seek medical assistance as soon as
possible. In case of a negative test result, the blood test
was to be repeated 12 hours later.
Web-based questionnaire
To evaluate the malaria prevention programme, an e-mail
invitation to answer a web-based questionnaire
(NetQuestionnaires version NETQ 6.0, the Netherlands)
was sent in July 2007 to 8,380 oilfield service company
employees, who were registered as non-immune to
malaria, and who might have travelled to, lived or worked
in a malarious area in the last two years. The survey cov-
ered use of the programme in these preceding 24 months.
The web-based questionnaire was accessible from July to
September 2007 by a unique link per addressed
employee, and could be opened only once. During this
period, several reminders were sent to the employees who
had not yet accessed the questionnaire. The answers to the
questionnaire were analysed anonymously. Gender, age
and country of birth was the only personal information
requested.
Definitions
Malaria was reported as
1. 'Doctor's diagnosis of malaria'; diagnosed by a local
doctor (not necessarily laboratory confirmed)
2. 'Laboratory confirmed malaria'; diagnosed by a local
doctor and confirmed by laboratoryMalaria Journal 2008, 7:128 http://www.malariajournal.com/content/7/1/128
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3. 'Presumptive malaria'; a positive self-test, or a clinically
diagnosed or laboratory confirmed malaria.
The following subgroups were defined:
- to analyse the effect of the malaria prevention pro-
gramme on several aspects concerning knowledge, atti-
tude and practices (KAP) of malaria:
1. 'Malaria Prevention Programme' as receiving the train-
ing for non-immunes with or without CMK
2. 'No Malaria Prevention Programme' as receiving nei-
ther training nor CMK.
- to analyse the effect of the CMK on malaria KAP:
1. 'CMK' as receiving the training and the kit
2. 'No CMK' as receiving the training without the kit.
Statistical analysis
Continuous data were analyzed with Students t-test, cate-
gorical data with Chi-square test or Fisher's exact test
where appropriate. Corrected relative risk (RR) was calcu-
lated from the corrected odds ratio (OR) obtained by
logistic regression. Corrected OR was recalculated into RR
according to the following formula: RR = OR/((1-
P)+(P*OR)), provided by Zhang and Yu [6], as the OR
overestimates the RR when prevalence (P) exceeds 10%.
Possible confounders for which was corrected by logistic
regression are specified for all reported results. P values
were provided for categorical data with more than two cat-
egories. Statistical analysis was performed using a compu-
ter-assisted software package (SPSS version 12.0, SPSS
Inc., Chicago, IL).
Results
The web-based questionnaire was opened by 3,575
employees, giving a total response rate of 43%. Of these
respondents, 2,552 reported to have travelled to malaria
endemic countries in the past 24 months, of whom 2350
(92%) completed the questionnaire entirely. Analysis of
the answers of all the respondents at risk and of those at
risk who completed the questionnaire did not yield differ-
ent results. Therefore, only the results of the completed
questionnaires are reported. The mean time to complete
the questionnaire was 12 minutes and 22 seconds.
Study population
The demographic characteristics of the studied popula-
tion are listed in Table 1.
The malaria countries visited are amongst those with the
highest incidence of P. falciparum [6]; in descending order
of frequency, the most visited countries were: Angola,
Cameroon, Nigeria, India, Gabon, Sudan, Equatorial
Guinea, Democratic Republic of Congo and Chad. Most
respondents visited more than one endemic country; the
median of endemic countries visited per respondent was
2 (range 1–105).
Risk of malaria
A comparison was made between the cumulative inci-
dences (CI) of malaria according to work status (Table 2).
The CI of acquiring malaria increased according to work
status and thus according to time spent in malaria
endemic countries. In addition, chemoprophylaxis use by
long term travellers was significantly lower (29%) com-
pared to that of rotators and visitors (both 62%) (p <
0.001). In contrast to the increasing CI of malaria with a
longer duration of stay, the CI of being hospitalized for
malaria was similar in all groups.
Ninety percent of the respondents who reported to have
had laboratory confirmed malaria acquired the disease in
sub-Saharan Africa. Malaria was acquired in descending
order of frequency in Sudan, Nigeria, Equatorial Guinea,
Angola, Chad, Cameroon, Republic of Congo, Gabon,
Ivory Coast, India, Benin, Somalia, Uganda and Peru. The
considerable burden of malaria in this population was
demonstrated by the fact that one-third (N = 648) of all
respondents visited a doctor for malaria symptoms and
almost half (29 of 68) of all hospitalizations were due to
laboratory confirmed malaria.
Table 1: Demographic characteristics of study population. 
Demographic characteristics N 
(N total 2350)
%
Gender Male 2065 88
Female 285 12
Age (yrs) mean (range) 36 (19–63) -
Continent of birth African 733 31
European 631 27
South American 328 14
Asian 301 13
North American 174 8
Arabic 102 4
Oceanian 64 3
Country of birth Malaria endemic$ 1392 60
Malaria non endemic 941 40
Working conditions Outdoor* 1278 54
Indoor 1072 46
Work status Long term (>6 months) 1122 48
Rotator 795 34
Visitor 342 15
Other (e.g. spouse) 91 4
Percentages may not add up to exactly one hundred due to rounding 
off. $ Malaria endemic country according to the WHO (5). *Outdoor 
working conditions include working on a land rig or with seismic 
crew, off shore, on another field location or on a marine vessel.Malaria Journal 2008, 7:128 http://www.malariajournal.com/content/7/1/128
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Malaria prevention programme
The mandatory malaria training for non-immunes was
completed by 92% of those who visited or worked in a
high risk malaria country. Overall, 70% of the respond-
ents at risk also received the CMK (Figure 1). Seventy-five
percent (N = 1229) of respondents who received the CMK
were instructed in how to use it, and all (98%) considered
the instructions to be clear.
Multivariate analysis showed that respondents who were
born in a malaria endemic country were two times less
likely to receive the malaria prevention programme [RR
2.0, 95% CI 1.4–2.7]. In addition, women were less likely
to receive the CMK [RR 1.4, 95% CI 1.1–1.7]. The effect of
the malaria prevention programme and the CMK on
malaria KAP was therefore corrected for these variables.
The distribution of the programme was not influenced by
work status, i.e. whether employees were long-term work-
ers, rotators or visitors, neither by working indoors or out-
doors.
Respondents receiving the malaria prevention pro-
gramme reported a twofold higher use of malaria chemo-
prophylaxis (47% vs. 19%) and had significantly more
knowledge about malaria. A similar effect was observed
for those who only received the CMK. Those who did not
receive the programme were twice as likely not to consider
malaria as a threat, nor to take additional anti-mosquito
measures (Table 3).
Despite the increased use of chemoprophylaxis by the
total group receiving the CMK, a small group (14%, N =
226) thought that having the CMK made regular malaria
chemoprophylaxis unnecessary. The use of chemoproph-
ylaxis in this group was 49% in comparison to 60% of
those who felt prophylaxis remained necessary with CMK
use (p = 0.001).
Use of self-test
One-third (N = 575) of the respondents who had received
the CMK performed the malaria self-test contained in the
CMK for presumptive malaria. Forty-nine test results were
positive (defined as a positive test result at first or repeated
Table 2: Cumulative incidence of malaria per 100 persons according to work status in 24 months. 
Cumulative incidence (%) 
of malaria in 24 months
[95%CI]
Visitor
(N = 342)
Rotator 
(N = 795)
Long term 
(N = 1122)
p-value*
Malaria Presumptive 2.3 
[0.7–3.9]
6.2 
[4.5–7.9]
13.7 
[11.7–15.7]
<0.001
Doctor's diagnosis 2.0 
[0.5–3.5]
5.7
[4.1–7.3]
12.8 
[10.8–14.8]
<0.001
Laboratory confirmed 1.8 
[0.4–3.2]
4.3
[2.9–5.7]
9.7
[8.0–11.4]
<0.001
Hospitalization for malaria Doctor's diagnosis 0.6 
[0.0–1.4]
1.6
[0.7–2.5] 1.5 [0.8–2.2]
0.6
Laboratory confirmed
0.6 [0.0–1.4]
1.6
[0.7–2.5]
1.2
[0.6–1.8]
0.5
*p-value for malaria diagnosis was obtained by χ2-test and for hospitalization with Fisher's exact test. Those who responded to belong to the 'other' 
group (N = 91), instead of the solicited groups, were excluded as their global time of possible exposure to malaria was unclear.
Distribution of the Malaria Prevention Programme in popula- tion at risk (N = 2350) Figure 1
Distribution of the Malaria Prevention Programme in 
population at risk (N = 2350). Numbers represent 
number of respondents receiving this part of the programme. 
Training = Training for non-immunes, CMK = Curative 
Malaria Kit.
TRAINING CMK
No programme
599 1573
108
70Malaria Journal 2008, 7:128 http://www.malariajournal.com/content/7/1/128
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testing), 508 negative and 18 invalid. Two-thirds (N =
378) repeated the test, giving a similar result in 79% (19
of 24), 99% (338 of 344) and 40% (4 of 10), respectively.
Although it was instructed to repeat the test after 12 hours
if the result was negative, only 55% (N = 189) adhered to
this instruction.
Fifteen percent of the respondents reported having diffi-
culties in using the self-test. Among those, the most fre-
quently reported difficulties were pricking the finger and
placing the blood drop on the test strip (Table 4).
Respondents who did not receive instructions with the
self-test were two-times more likely to have difficulties
[RR = 2.3, 95%CI 1.6–3.3] and three-times more likely to
have an invalid test [RR = 2.9, 95%CI 1.0–8.5]. Respond-
ents with difficulties were 30 times more likely to have an
invalid test result [RR = 29.6, 95%CI 8.2–106.4], after cor-
rection for possible confounding of receiving instructions.
Use of medical care
Almost twice as many respondents with a positive result
visited a doctor for malaria symptoms, and a positive test
indicated a tenfold higher risk of being diagnosed with
malaria. On the other hand, 6% (31 of 513) of those with
a negative test result were still diagnosed with malaria by
a local doctor, although this diagnosis was 1.5 times less
likely to be confirmed by a laboratory (Table 5).
When hospitalization was employed as an indicator for
severity of malaria, performing a test before visiting a doc-
tor for malaria symptoms did not result in more severe
malaria in comparison to immediately visiting a doctor
(respectively 12%, and 14% hospitalization in those with
doctor's diagnosis of malaria, p = 1.0) (table 5). In addi-
tion, respondents in whom malaria was diagnosed despite
a negative test result, had a similar hospitalization rate
(13%).
Table 3: Effect of Malaria Prevention Programme on malaria KAP
Malaria Prevention Programme Curative Malaria Kit
Malaria Knowlegde, 
Attitudes and Practices
Training and/or CMK No training and no 
CMK
RR 
[95%CI]
Corrected 
RR# 
[95%CI]
Training 
with 
CMK
Training 
w/o CMK
RR 
[95%CI]
Corrected
RR#
[95%CI]
Chemical prophylaxis 
use n/N (%)
1049/2242
(47)
21/108
(19)
2.4
[1.8–3.0]
2.5$
[1.9–3.2]
861/1573
(55)
171/599
(29)
1.9 
[1.7–2.1]
1.9$ 
[1.6–2.0]
Not considering 
malaria as a threat n/N 
(%)
126/1873
(7)
13/97
(13)
0.5
[0.3–0.9]
0.4 
[0.2–0.8]
69/1337
(5)
53/480
(11)
0.5
[0.3–0.7]
0.5 
[0.3–0.7]
Not inclined to take 
anti mosquito 
measures n/N (%)
103/1746
(6)
16/78 
(21)
0.3 
[0.2–0.5]
0.3 
[0.2–0.5]
58/1236
(5)
39/453
(9)
0.6 
[0.4–0.8]
0.5 
[0.3–0.8]
Correct malaria 
knowlegde* n/N (%)
977/2242
(40)
28/108
(26)
1.7 
[1.3–2.1]
1.6 
[1.2–2.1]
745/1573 
(47)
202/599 
(34)
1.4 
[1.3–1.6]
1.4 
[1.2–1.5]
RR = Relative Risk.
#Corrected for malaria endemic country of birth.
$Additionally corrected for work status (long term traveller, rotator, etc.).
*Knowlegde was examined by multiple choice question on the maximum incubation time of Plasmodium falciparum. The denominators for questions 
on considering malaria as a threat and inclination to take anti-mosquito measures vary, as answers reporting 'neutral' were not used for analysis.
Table 4: Difficulties with self-test contained in the CMK reported by respondents who used the test. 
Difficulties with self-test N (%)
Respondents reporting difficulties N performing self-test = 575 85 (15)
Difficulties N total = 85 Finger prick 50 (59)
Placing blood drop 24 (28)
Result interpretation 15 (18)
Identifying lines 13 (15)
Technical problem kit 12 (14)
Instructions 10 (13)
Adherence to waiting time 2 (2)
Too ill to perform test 1 (1)
More than one difficulty could be reported per respondent.Malaria Journal 2008, 7:128 http://www.malariajournal.com/content/7/1/128
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Standby emergency treatment
One fifth (N = 441) of the respondents took curative med-
ication for malaria. The origin of the curative medication
was mostly the CMK (39%) or a local hospital (35%).
Ninety percent (N = 44) of the respondent with a positive
test result and 22% (N = 115) of the respondents with a
negative test result took curative medication.
Fifty seven percent (N = 252) of respondents who took
curative medication did not have presumptive malaria.
The source of this inappropriately used curative medica-
tion was two times more likely to be the CMK than the
medication used by those with presumptive malaria (50%
vs. 25% respectively).
Effect of the malaria prevention programme on the 
outcome of malaria
1.1% (N = 25) of the respondents who had received the
malaria prevention programme was hospitalized for labo-
ratory confirmed malaria in comparison to 3.7% (N = 4)
of those who did not receive the programme [RR = 0.3,
95%CI 0.1–0.9]. However, when corrected for birth in a
malaria endemic country the risk of hospitalization was
not significantly reduced [RR = 0.4, 95%CI 0.1–1.1].
There was no significant reduction in hospitalization for
those who had received the CMK without training.
Discussion
Falciparum malaria is a severe disease and international
employees and contractors working in highly endemic
malarious areas are particularly at risk. In this study, it was
found that one per 200 employees per year was hospital-
ized because of laboratory confirmed malaria, and 90% of
malaria was acquired in sub-Saharan Africa. The self-test
was positive in 8% of the respondents. Malaria was also
diagnosed by a medical doctor in 6% of the repondents
with a negative test. The malaria awareness training and
self-diagnosis and treatment had a significant positive
effect on knowledge and attitude towards malaria preven-
tion and doubled the use of malaria chemoprophylaxis.
This study also suggests a reduction in hospitalization for
malaria, thus reducing malaria associated morbidity.
Several limitations of this study require attention. First,
not all employees responded to the invitation (response
rate was 43%), possibly inducing a responder bias. This
may have led to an overestimation of the uptake of the
programme. On the other hand, some of the respondents
did not or partly receive the programme, which allowed to
draw seperate conclusions on the contribution of aware-
ness training and CMK. Secondly, neither the result of the
self-test nor the diagnosis of malaria by doctor or labora-
tory was confirmed by an independent test. Therefore, the
accuracy of the interpretation of the self-test result by
these febrile expatriates remains unknown. However, the
endpoint of malaria was considered to be equally
(in)accurate in all respondents, meaning that no diagno-
sis bias was introduced.
This survey showed that sub-Saharan Africa continued to
pose the highest risk for the acquisition of malaria, and
that long term residents are at the highest risk to contract
Table 5: Influence of test performance and result (positive if first or repeated test result was positive) on doctor visit and malaria 
diagnosis and hospitalization.
CMK received
Self-test performed Self-test not performed N = 1068
Self-test result RR 
[95%CI]
Corrected 
RR# 
[95%CI]
Positive 
N = 49
Negative 
N = 508
Visited doctor for malaria symptoms N Yes (%) 40 
(82)
233 
(46)
1.8
[1.5–2.0]
1.8 
[1.4–2.0]
177 
(17)
Doctor's diagnosis malaria N Yes (%) 33 
(67)
31 
(6)
11.0 
[8.3–13.2]
10.3 
[7.4–12.8]
59 
(6)
Laboratory confirmed malaria N Yes (%) 28* 
(85)
18* 
(58)
1.5
[1.1–1.7]
1.5
[1.2–1.7]
47* 
(80)
Hospitalization for malaria N Yes (%) 4* 
(12)
4* 
(13)
0.9
[0.2–2.9]
1.0 
[0.2–3.0]
8*
(14)
RR = Relative Risk.
#RR is corrected for malaria endemic country of birth.
*Denominator is respondents with a doctor's diagnosis of malaria.Malaria Journal 2008, 7:128 http://www.malariajournal.com/content/7/1/128
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malaria, although they were not more likely to be hospi-
talized than rotators or visitors. This could reflect the
experience long term travellers have with malaria, being
more aware of its symptoms.
The present study confirmed that the compliance of expa-
triate workers to malaria prophylaxis was poor [7] and
decreased with duration of stay [8]. Fifty-five percent of
the respondents did not take malaria chemoprophylaxis;
for comparison in travellers on vacation in high-risk areas
this was 16% [2]. The availability of self-testing and
standby treatment with CMK may offer non-compliant
employees an additional safe guard against the serious
consequences of falciparum malaria if proper medical
care is not available. In addition, the introduction of the
malaria awareness training and CMK significantly
increased compliance to malaria prophylaxis. Despite this
increased compliance, 14% of those who received the
CMK thought that having the kit made regular chemo-
prophylaxis unnecessary. Although many of the respond-
ents who felt this way actually did use prophylaxis. The
importance of continuing prophylaxis use despite the
availability of standby treatment warrants special empha-
sis in any educational programme.
In experienced hands, the immunological antigen-capture
self-test for P. falciparum histidine-rich protein-2 or lactate
dehydrogenase has shown to be accurate and reliable
diagnostic tests for P. falciparum infection [9]. However,
the correct performance of these dipstick-based rapid tests
in febrile travelers may vary from 69% to 91% depending
on whether prior instructions were given [10-12]. In the
present study, 15% reported difficulties with performing
the self-test, and the fact that not receiving CMK instruc-
tions was significantly associated with difficulties and
invalid test results clearly underscores the need for proper
instructions. Only 67% adhered to the instruction to
repeat the self-test in case of a negative test result, and
55% adhered to the instructed time interval. The reason
for non-adherence to these instructions is unknown. One
possibility is that the self-test was not repeated because
malaria symptoms had spontaneously resolved. It should
be emphasized during the training that repeating the self-
test within six hours after a first negative test result is
unlikely to be useful as parasitaemia may still be too low
to detect.
The introduction of a self-test for malaria aims at decreas-
ing treatment delay in case of a positive test result in the
absence of medical care, and at reducing the empirical use
of standby treatment medication in case of fever and a
negative test result. On the contrary, introduction of a self-
test for malaria may increase patients' delay and lead to
more severe malaria in case of false negative test result.
However, the hospitalization rate of respondents with a
negative test result who were subsequently diagnosed
with malaria by a doctor was not significantly increased.
This suggests that these patients did not have severe
malaria more frequently.
Six percent of respondents who tested negative were still
diagnosed with malaria. However, this diagnosis was less
likely to be confirmed by a laboratory. It may reflect the
possibility of overdiagnosis of malaria by a doctor, since
there is anecdotal evidence that in Africa it is common
practice to assume malaria, often irrespective of actual
complaints [13]. The use of molecular diagnostics has the
potential to overcome these limitations. When a finger
prick for self-testing is performed we would recommend
storing a few drops of blood on filter paper as well for PCR
analysis for P. falciparum after returning home. This would
enable future determination of true positive and true neg-
ative rates for self-testing and clinical diagnosis of falci-
parum malaria abroad.
The use of a self-test had a clear effect on restrictive use of
standby medication: 77% of the respondents who had a
negative test result did not take standby medication.
Standby treatment was used not only by respondents with
a positive self-test or medical diagnosis of malaria, but
also in 57% who did not have a diagnosis of malaria, a
number which has also been reported by others [14,15].
The CMK may have facilitated this inappropriate use, as
the curative medication used by respondents without pre-
sumptive malaria originated in 50% from the CMK. This
aspect will require future scrutiny; the improper use of
self-treatment may result in unnecessary exposure to side-
effects and in a delay of diagnosis and treatment of other
potentially life threatening diseases.
Conclusion
This survey demonstrates that, with proper instruction
and training, a preventive malaria programme can con-
tribute to the awareness of the risks of this disease. The
components of this programme that deserve attention are
the instructions on the performance of the self-test, the
correct use of the curative medication and the need to seek
medical care regardless of use of CMK. As it is impossible
to make all travellers, irrespective of their purpose or dura-
tion of travel, adhere one hundred percent to every pre-
ventive measure, the contribution of the separate
components which raise awareness and protection is
cumulative. For those travellers considered to be exposed
to higher risks of infection, such as expatriates, this
malaria prevention programme certainly is such a compo-
nent. Its strength lies in the multi-step design, in which a
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